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Abstract
Complex human physiological processes create the stable isotopic composition of exhaled carbon
dioxide (eCO2), measurable with noninvasive breath tests. Recently, isotope-selective breath tests
utilizing natural fluctuation in 18O/16O isotope ratio in eCO2 have been proposed for screening
prediabetic (PD) individuals. It has been suggested that 18O/16O fractionation patterns reflect shifts
in the activity of carbonic anhydrase (CA), an enzyme involved in the metabolic changes in the PD
state. To evaluate the applicability of the breath sampling method in Finnish PD individuals, breath
delta values (BDVs, ‰) of 18O/16O (δ18O) were monitored for 120 min in real-time with a
high-precision optical isotope ratio spectrometer, both in the fasting state and during a 2 h oral
glucose tolerance test (2 h OGTT) with non-labeled glucose. In addition, the BDV of 13C/12C
(δ13C) was measured, and total erythrocyte CA activity was determined. δ18O and CA did not
demonstrate any statistically significant differences between PD and non-diabetic control (NDC)
participants. Instead, δ13C was significantly lower in PD patients in comparison to NDCs in the
fasting state and at time points 90 and 120 min of the 2 h OGTT, thus indicating slightly better
potential in identifying Finnish PD individuals. However, overlapping values were measured in PD
participants and NDCs, and therefore, δ13C cannot be applied as a sole measure in screening
prediabetes at an individual level. Thus, because the combination of environmental and lifestyle
factors and anthropometric parameters has a greater effect on glucose metabolism and CA activity
in comparison to the PD state, 18O/16O and 13C/12C fractionations or CA activity did not prove to
be reliable biomarkers for impaired glucose tolerance in Finnish subjects.
This study was conducted under the clinicaltrials.gov ID NCT03156478.
1. Introduction
The stable isotopic composition of exhaled carbon
dioxide (eCO2) displays characteristics of the phys-
ical process of origin of the molecule. Thus, isotopic
recovery via noninvasive breath tests can provide
signatures, for example, for many complex human
physiological phenomena, such as diseases, medical
conditions, energy consumption, and changes in vari-
ous body functions [1, 2].
The stable isotope breath tests are commonly
based on ingestion of a carbon-13 (13C)-labeled sub-
strate, which is converted into 13CO2 via metabolism
and is detected as a change in the baseline 13C/12C
ratio in eCO2. The most well-known example among
isotope-selective breath tests is the 13C-labeled urea
breath test (13C-UBT), used to identify Helicobacter
pylori infection.United States Food andDrugAdmin-
istration has approved the 13C-UBT already in the
1990s. Labeled 13C tracers have also been used to
© 2021 The Author(s). Published by IOP Publishing Ltd
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assess insulin sensitivity [3] and glucose uptake [4]
as well as in numerous applications of medicine [5]
and nutrition [6]. Along with labeled 13C, the meas-
urement of oxygen-16 (16O) and oxygen-18 (18O) iso-
topes in exhaled breath can be exploited in noninvas-
ive studies and diagnostic approaches [7–9].
The latest research lines in the field of isotope-
selective breath testing include early sepsis and infec-
tion detection [7, 10–12] and prediabetes (PD) and
type 2 diabetes (T2D) screening [8]. These applica-
tions are based on monitoring the breath delta val-
ues (BDVs, ‰) of 18O/16O and/or 13C/12C in eCO2
(i.e. δ18O and δ13C) and rely on the natural fluctu-
ation in the isotope ratios during innate or induced
metabolic events [2, 9, 11]; thus, no labeling is used.
Typically, delta-over-baseline (DOB, ‰) values, i.e.
shift in BDV in relation to the baseline, are utilized
in diagnostic purposes. BDVs of 18O/16O and 13C/12C
are often calculated in relation to an international
Vienna Pee Dee Belminite (VPDB) standard. DOB
values (i.e. δDOB18O and δDOB13C) are calculated as
described: DOB= BDVsample − BDVbaseline. Recently,
there have been attempts to utilize δ13C, as such, for
example in sepsis detection and severity evaluation
[10], and in supportingweight-management bymon-
itoring energy metabolism [13].
Based on the recent studies by Ghosh et al [8],
monitoring of 18O/16O isotope ratios during the 2 h
oral glucose tolerance test (2 h OGTT) provides a
potential non-invasive method for the assessment of
glycated hemoglobin (HbA1c) and insulin sensitiv-
ity in Indian participants with PD and T2D. Fur-
thermore, they proposed that 18O/16O fractionation
patterns reflect carbonic anhydrase (CA) activity in
PD individuals and T2D patients: fasting CA activity
was shown to be reduced in T2D patients in compar-
ison to PD and non-diabetic controls (NDCs), and
this phenomenon was suggested to be related to the
increased glycosylation of CA in T2D patients [8].
CA enzymes, divided into 7 subgroups and compris-
ing 15 isoforms, are present in various human tis-
sues, and catalyze the conversion of CO2 to bicarbon-
ate (HCO3−) in blood and tissues, thus participating
in the pH regulation of the human body [14]. Ghosh
et al [8] suggested that while CA also induces the
efficient exchange of oxygen isotopes between blood
plasmaH218Oand 12C16O2 during respiration, higher
CA activity results in a higher 18O/16Oratio in exhaled
breath. That is, a change in CA activity can be seen as
a shift in δ18O in eCO2, reflecting the 18O/16O ratio
in body H2O and CO2. Changes in CA activity seem
to be involved in the altered metabolism in different
stages of T2D [15], and thus, isotopic enrichment of
18O in eCO2 could be observed in PD individuals and
T2D patients [8].
However, the δ18O in the fasting state and dur-
ing the 2 h OGTT were not reported by Ghosh et al
[8], and the δDOB18O values were used to express the
18O/16O stable isotope ratios. Thus, to evaluate the
more universal applicability of the breath sampling
method and to study the potential trends in 18O/16O
isotopic fractionation in the fasting state or during the
2 h OGTT, δ18O was monitored in Finnish PD indi-
viduals for 120 min in real-time with a compact VTT
IsoMed Breath CO2 isotope analyzer [16]. Further-
more, CA activity and HbA1c concentrations were
measured to study the correlations between fasting
δ18O and HbA1c levels and CA activity. In addition,
as breath 13C/12C isotope ratio has been established
as a valuable biomarker in the assessment of insulin
resistance in tracer approaches [17, 18], breath δ13C
was measured simultaneously to investigate whether
this approach would provide new means for the eval-
uation of T2D prognosis. The anthropometric meas-
ures of the participants were also surveyed against
δ18O, δ13C, and CA activity. Furthermore, several
clinically relevant blood values were screened in the
fasting state and during the 2 h OGTT for potential
interactions between CO2 isotopic fractionations and
the prediabetic (PD) state.
2. Materials andmethods
2.1. Study subjects
Two groups of participants, consisting of men and
women aged 40–65, were recruited for the study.
Altogether, 30 PD individuals were recruited among
the participants in the ongoing StopDia study [19].
The StopDia study was approved by the Research Eth-
ics Committee of Hospital District of Northern Savo
(statement number 467/2016). The inclusion criteria
for the PDparticipants were: BMI 25–35 kgm−2, fast-
ing plasma glucose 5.6–6.9 mmol l−1, and 2 h OGTT
plasma glucose 7.8–11.0 mmol l−1. The 19 NDC par-
ticipants were recruited via e-mail or intranet notific-
ation to the staff of the University of Eastern Finland
and Kuopio University Hospital. The extension of the
study group with NDC individuals was approved by
the Research Ethics Committee of Hospital District of
Northern Savo (statement number 542/2017). Writ-
ten informed consent to participate in the study and
the use of data from national health care registries
were obtained from all participants. The study was
conducted according to the Responsible Conduct of
Research by the Finnish Advisory Board on Research
Integrity and the Declaration of Helsinki.
The participants arrived in the laboratory in the
morning after 12 h fasting. At the beginning of the
visit, all participants were weighed, and waist cir-
cumference and systolic and diastolic blood pressure
weremeasured. The participants were interviewed for
their health status and recent travel history. The parti-
cipants were randomly selected to go through a short
test routine, or a long test routine involving the 2 h
OGTT: 10 of the 19 NDC participants and 15 of the
30 PD participants continued to the 2 h OGTT.
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2.2. Breath sampling
For all participants, a maximum 5 min breath
sampling was performed with nasal cannula to
determine the fasting state δ18O and δ13C. The iso-
topes were measured with a high-precision optical
isotope ratio spectrometer (OIRS) developed by VTT
Technical Research Centre of Finland [16]. The spec-
trometer is based on a direct absorption approach
using a tunable mid-infrared Interband Cascade
Laser. The molecular absorption frequencies of car-
bon dioxide isotopologues are slightly shifted due to
mass difference. This allows for the selective detec-
tion of the three most abundant isotopes of CO2
in a compact device. Water was removed from the
sample using Silica gel capsules, prior introduc-
tion to the measurement cell of the spectrometer.
The sample gas was actively compared to an iso-
tope standard with a known isotope ratio, previ-
ously analyzed by the Max-Planck Institute for Bio-
chemistry [20]. The analysis routine was validated
by using gas standards of different mixtures. The
precision of the DOB measurements is verified to
be within 0.1 ‰ and the absolute accuracy of the
BDV within 0.3 ‰ (1 sigma standard deviation)




The NDC participants were subjected to screening
blood tests, including blood count, serum thyroid-
stimulating hormone, creatinine, alanine amino-
transferase, and alkaline phosphatase. The blood
sample used for screening tests was collected concur-
rently with the fasting blood sample; the PD parti-
cipants had beenpreviously screened during the Stop-
Dia study.
The screening blood samples and/or fasting blood
samples were collected immediately after breath
sampling. The fasting blood sample was analyzed for
plasma glucose, serum insulin, HbA1c, blood hemo-
globin, high-sensitivity C-reactive protein, and eryth-
rocyte hemoglobin concentrations.
Blood samples were analyzed by the methodo-
logy currently in routine use at the Institute of Public
Health and Clinical Nutrition and Clinical Research
Unit at the University of Eastern Finland and the
Clinical Chemistry Laboratory at the Kuopio Uni-
versity Hospital. Blood glucose levels were analyzed
using the Konelab 20XTi Clinical Chemistry Ana-
lyser (Thermo Fisher Scientific, Waltham, MS, U.S.)
and an enzymatic photometric (glucose hexokinase)
method, and serum insulin levels were analyzed
with a chemiluminescent immunoassay. HbA1c (%)
was determined by high performance liquid chro-
matography by utilizing an HbA1c analyzer. High-
sensitivity C-reactive protein concentrations were
determined by nephelometry (Siemens, Eschborn,
Germany).
2.4. CA activity
Total erythrocyte CA activity was determined accord-
ing to Ghosh et al [8] from fasting and 2 h OGTT
blood samples. In brief, the procedure was as follows:
erythrocytes were isolated from fresh EDTA plasma
samples by centrifugation. After lysing the erythro-
cytes, the resulting hemolysate was used for the CA
activity measurement. The CA activity was determ-
ined spectrophotometrically from the hydrolysis rate
of p-nitrophenyl acetate to p-nitrophenol, monitor-
ing the increase in absorbance at 348 nm. As there are
other esterases present in the hemolysate, reactions
were executed in the presence of a specific inhibitor
of CA, acetazolamide. The total CA activity was calcu-
lated from the difference in change of optical densities
in the presence and absence of acetazolamide.
2.5. 2 h OGTT
For all participants going through the long test
routine with 2 h OGTT, after collection of the fast-
ing blood sample, a beverage containing 75 g of non-
labeled glucose was given; the fasting blood sample
served also as the pre-glucose-load blood sample of
the 2 h OGTT. Blood samples were collected at 30,
60, 90 and 120min after the bolus of glucose andwere
analyzed for plasma glucose and serum insulin levels
as well as CA activity. The isotopemeasurements were
conducted in real-time throughout the 2 h OGTT,
using a nasal cannula. For eachmeasurement, the iso-
tope reading was averaged around 5 min to reduce
the standard deviation of the measurement, but also
to average potential short-term variations of the iso-
topes in patient breath.
2.6. Statistical analyses
The anthropometric measures and breath test val-
ues were statistically tested with the SPSS software,
Version 27 (IBM SPSS Statistics for Windows, IBM,
Armonk, New York, U.S.). Analysis of variance was
used for normally distributed variables. Kruskal–
Wallis test was used for variables with skewed dis-
tributions and for pairwise comparisons of δDOB18O,
δDOB
13C, and ∆CA at each time point. Correlations
among variables were analyzed using Pearson’s coef-
ficients for correlation. The p-value threshold for stat-
istical significance was set at 0.05.
3. Results
Anthropometrics, fasting blood glucose, fasting
serum insulin,HbA1c, isotopic fractionations andCA
activity in the study groups are presented in table 1.
For PD participants, the mean changes in CA
activity the (∆CA; U min−1 ml−1) increased dur-
ing the whole 120 min of 2 h OGTT (figure 1;
table S1 which is available online at stacks.iop.org/
JBR/15/021001/mmedia). The mean δDOB18O (‰)
showed fluctuation first increasing (30 min), then
3
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Table 1. The anthropometric and diagnostic blood values, CA activity levels, and breath delta values (δ18O, δ13C) (±standard deviation)
in NDC subjects (n= 19) and in PD participants (n= 30). CA activity, δ18O, and δ13C were monitored in 30 min intervals for NDC
(n= 10) and PD (n= 15) subjects participating the long test routine with 2 h OGTT.
NDC PD sig.
Sex (male/female) 7/12 10/20
Age (years) 52.9± 7.9 59.1± 8.2 0.012d
Weight (kg) 75.5± 16.4 85.7± 14.3 0.025d
BMI (kg m−2) 25.5± 3.7 30.4± 3.6 0.000d
Waist (cm) 87.3± 3.0 100.5± 10.5 0.000d
Waist-to-height ratio 0.5± 0.1 0.6± 0.1 0.000d
Fasting plasma glucose (mmol l−1) 5.5± 0.4 6.1± 0.6 0.000d
Fasting plasma insulin (mU l−1) 7.0± 4.9 15.0± 9.9 0.001d
HbA1c (mmol mol−1) 33.9± 2.3 38.0± 1.8 0.000d
Fasting CA activity (U min−1 ml−1) 5.2± 0.9 5.0± 0.8 0.412
Fasting δ18O (‰) −5.6± 1.0a −6.0± 1.3 0.244
Fasting δ13C (‰) −27.4± 0.6a −27.8± 0.7 0.048d
2 h OGTT NDCb PDc sig.
Fasting CA activity (U min−1 ml−1) 5.2± 0.9 4.7± 0.9 0.180
CA activity (U min−1 ml−1) 30 min 5.4± 0.8 4.9± 0.8 0.154
CA activity (U min−1 ml−1) 60 min 5.2± 0.4 4.9± 0.8 0.372
CA activity (U min−1 ml−1) 90 min 5.4± 0.9 5.0± 0.7 0.290
CA activity (U min−1 ml−1) 120 min 5.5± 0.6 5.3± 0.9 0.529
Fasting δ18O (‰) −5.6± 1.0 −6.2± 1.4 0.295
δ18O (‰) 30 min −5.8± 1.0 −6.2± 1.5 0.561
δ18O (‰) 60 min −5.8± 1.0 −6.2± 1.5 0.467
δ18O (‰) 90 min −5.8± 1.1 −6.1± 1.5 0.621
δ18O (‰) 120 min −5.9± 1.1 −6.2± 1.5 0.605
Fasting δ13C (‰) −27.3± 0.8 −27.6± 0.6 0.246
δ13C (‰) 30 min −26.8± 0.7 −27.1± 0.5 0.375
δ13C (‰) 60 min −26.8± 0.7 −26.3± 0.6 0.085
δ13C (‰) 90 min −24.5± 0.8 −25.3± 0.7 0.025d




d Statistically significant (sig.) difference, p-value < 0.05.
decreasing (60 min), and then increasing again
(90min); and finally, slightly decreasing at time point
120 min (figure 2). For NDC subjects, ∆CA was,
on average, increased during the first 30 min of 2 h
OGTT, and after that, at time point 60 min,∆CAwas
decreased close to the initial value measured at the
time point 0 (figure 1). At time points 90 and 120min,
∆CA was increasing in NDC group. Meanwhile,
δDOB
18Owas first decreased (at 30 min), then slightly
increased (at 60 min), and again decreased (at 90
and 120 min) (figure 2). At time point 30 min, there
was a significant difference (p = 0.037) in δDOB18O
between groups. δDOB13C was more steeply increased
in NDC group during the 2 h OGTT (figure 3;
table S1).
The absolute CA activity measures and δ18O
were, on average, slightly lower in PD participants
in comparison to NDC group at all time points of
measurement (table 1). However, the fluctuations in
CA activity levels and in δ18Owereminor and showed
no statistically significant differences between the two
study groups. Fasting δ13C was significantly lower in
PD participants (n= 30) in comparison to NDC sub-
jects (n = 19) (table 1), and at time points 90 and
120 min of the 2 h OGTT, δ13C was decreased to a
significantly lower level in PD versus NDC subjects.
Fasting δ13C showed negative correlation with fast-
ing HbA1C level (r = −0.306, p < 0.05); however,
there was no significant correlation between fasting
HbA1C level and fasting δ18O or fasting CA activity.
Instead, fasting δ18O was found to positively correl-
ate with age (r = 0.339, p < 0.05), and the fasting
state CA activities showed small but significant neg-
ative correlation with participant’ body mass index
(BMI; kg m−2) (r =−0.286, p < 0.05). Furthermore,
BMI was significantly higher in PD group (table 1).
Indeed, as expected, higher BMI, waist circumfer-
ence, waist-to-height ratio, blood insulin and glucose
levels, as well as HbA1c values served as moder-
ate indicators of PD status. However, overlapping
in the measured values was observed in the par-
ticipant groups. Other blood sample values show-
ing statistically significant differences between NDC
and PD groups were: leucocyte count, erythrocyte
4
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Figure 1. Temporal changes in the measured CA activities (∆CA, U min−1 ml−1) in NDC subjects (n= 10) and PD individuals
(n= 15) during the 2 h OGTT. Box plot shows the median and 25% and 75% interquartile range; x represents the mean.
Whiskers show the minimum and maximum values.
count, hemoglobin, hematocrit, mean corpuscular
volume (MCV), high-sensitivity C-reactive protein,
and plasma alkaline phosphatase (data not shown).
All values were positively interrelated with PD state,
except for MCV, which was, on average, higher in
NDC subjects.
4. Discussion
Based on the results of this study, measuring δ13C
during 2 h OGTT could support the identification
Finnish PD individuals, as characteristic δ13C in PD
and NDC subjects seemed to indicate the differences
in insulin response and glucose metabolism between
the study groups. The shift in isotopic fractionation of
breath CO2 after ingesting a bolus of glucose reflects
the rate of glucose absorption, insulin response, and
glucose uptake in tissues [17]. In previous studies it
has also been found that breath δDOB13C serves as an
indicator ofH. pylori infection, known to affect gluc-
ose metabolism, when unlabeled glucose has been
applied in OGTT [7]. Thus, the more pronounced
appearance and slower depletion of 13C in eCO2 dur-
ing the 2 h OGTT indicates that glucose is more
effectively metabolized in NDC subjects in compar-
ison to PD participants of our study. Nevertheless,
because overlapping values were measured in PD and
NDC subjects in our analyses, δ13C cannot be recom-
mended as an only measure in screening prediabetes
on an individual level.
The results of the present study indicated that
the CA activity steadily increased during the 120 min
of the 2 h OGTT in the PD individuals and slightly
decreased during the first 60 min of the 2 h OGTT in
the NDC individuals. Thus, our results were in line
with the results of Ghosh et al [8] who showed that
CA activity clearly increased in PD individuals and
steeply decreased in NDC individuals during the 2 h
OGTT; however, Ghosh et al [8] had a single meas-
ure at 120 min after the glucose dose, while we had
measurements every 30 min during the 2 h OGTT. In
contrast to Ghosh et al [8], we found no statistically
significant differences between the study groups. In
addition, in our study∆CA were smaller, and the CA
activity increased above the fasting level in the NDC
individuals.
For δDOB18O, our results showed that in PD par-
ticipants, on average, there were no notable mean
changes, although a minor increase in δDOB18O could
be observed at time point 90 min; in the case of NDC
subjects, δDOB18O was slightly decreased within the
120 min trial. Instead, Ghosh et al [8] observed that
for PD patients, the δDOB18O was sharply increased
within 120 min of OGTT, and for NDC subjects, the
values were clearly decreased; in their study, δDOB18O
determined at time point 120 was significantly differ-
ent between PD andNDC groups. In our study, signi-
ficant difference was observed at time point 30 min.
Importantly, although the trends in the average
values for CA activity and δDOB18O values in Finnish
study subjects were in line with the results of Ghosh
et al [8], there were large variations in the CA activ-
ity and 18O/16O fractionation patterns between indi-
viduals across the study groups. Thus, these meas-
ures were not proved as reliable biomarkers for health
status in Finnish subjects. Overall, because the biotic
and abiotic factors affecting the stable oxygen isotopic
values in mammals are complex, it may be difficult to
5
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Figure 2. Temporal changes in the measured 18O/16O delta over base values (δDOB18O,‰) in NDC subjects (n= 10) and PD
individuals (n= 15) during the 2 h OGTT. Box plot shows the median and 25% and 75% interquartile range; x represents the
mean. Whiskers show the minimum and maximum values. Significant difference (p= 0.037) between PD and NDC groups is
indicated with asterisk (∗) at time point 30 min.
Figure 3. Temporal changes in the measured 13C/12C delta over base values (δDOB13C,‰) in NDC subjects (n= 10) and PD
individuals (n= 15) during the 2 h OGTT. Box plot shows the median and 25% and 75% interquartile range; x represents the
mean. Whiskers show the minimum and maximum values.
compare oxygen isotopic data collected from differ-
ent study sites [21]. The diet, drinking water, exer-
cise routines, and for example, smoking affect the
oxygen isotope fractionation in humans [2]. Drink-
ing water oxygen isotopic composition has major dif-
ferences between Finland and India [22], and these
differences may partially explain the poor applicabil-
ity of themethod in screening Finnish PD individuals.
In addition, hormone-mediated responses and other
metabolic differences between study groupsmay have
an effect on the 18O depletion levels [21].
Based on our results it is also suggested that the
ratio can change in response to the age of the study
subject, as fasting δ18O was significantly positively
correlated with age in the present study. The mean
age in the study of Ghosh et al [8] was 36.0 ± 7.5
and 34.6± 6.5 years (p > 0.05) for NDC and PD sub-
jects, respectively, as in the current study, the mean
6
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age was 53.0 ± 7.9 and 59.2 ± 8.2 years (p < 0.05)
for NDC and PD subjects, respectively. Thus, the dif-
ferences in living environments, lifestyles, and age-
related parameters might be reflected in the differing
changes in δ18O during 2 h OGTT observed between
PD and NDC groups in this study in comparison to
Ghosh et al [8]. It should be noted that the measuring
accuracy of the OIRS equipment used in our study is
comparable to the measuring accuracy of the isotopic
CO2 integrated cavity output spectrometer utilized by
Ghosh et al [8].
It has been found that CA activity level is some-
what reduced in young obese PD patients in rela-
tion to healthy normal-weight subjects, although this
reduction was not statistically significant [23]. Actu-
ally, the CA activity was slightly positively correl-
ated with obese subjects’ BMI [23]. In our data,
the absolute CA activity measures were, on aver-
age, slightly lower in PD participants in comparison
to NDC group at all time points of measurement,
and the fasting state CA activity levels (5.2 ± 0.9
and 5.0 ± 0.8 for NDC and PD subjects, respect-
ively; p = 0.412) were negatively correlated with
the subjects’ BMI. Malheiro et al [23] have sug-
gested that in PD children with BMI higher than
40 kg m−2, CA activity levels would be increased in
comparison to overweight subjects with lower level of
obesity. In our study, the average BMI in PD group
was 30.4 ± 3.6 kg m−2 while the average BMI in
NDC group was 25.5 ± 3.7 kg m−2. Thus, no par-
ticipant had BMI higher than 37.9 kg m−2, and the
low-to-moderate level of obesity in the participants
in PD group would explain the negative analogue
between BMI and CA activity. This possible relation-
ship between low-to-moderate level of obesity and
CAactivity is also slightly supportedwhen the Finnish
and Indian studies are compared: our Finnish subjects
had higher BMI, as well as lower fasting CA activity
levels in both NDC and PD groups, in comparison
to the study groups of Ghosh et al [8]. Indeed, the
average BMI was 24.28± 2.8 and 24.17± 2.4 kg m−2
(p = 0.877) and the average fasting CA activity level
was 9.18 ± 1.2 and 8.98 ± 1.2 U min−1 ml−1
(p < 0.001), for the Indian NDC and PD subjects,
respectively [8]. Moreover, in our study, the mean age
was 52.9 ± 7.9 and 59.1 ± 8.2 years for NDC and
PD groups, respectively, which may further highlight
the negative correlation. It should also be taken into
account that measuring total erythrocytic CA activ-
ity includes the activities of several CA isozymes; this
may mask the variable activity levels of different CA
isozymes in PD andNDC subjects and complicate the
interpretation of the CA activity results [23].
Biswas and Kumar [24] have observed in their
in vitro studies that CA activity may increase in short
term as a result of enhanced methylglyoxal (MG)
levels, often measured in insulin resistant patients.
MG synthesis is triggered by high blood sugar levels
and further enhanced if the person has developed
insulin resistance [24]. MG is considered as a toxic
substance, and it is involved in protein glycation
reactions affecting erythrocyte membrane integrity,
insulin reactivity, as well as CA activity [24]. AsMG is
produced via secondary activities of glycolysis, func-
tioning under both genetic and environmental reg-
ulation [25], there is a chance that the inconsist-
ent relationship between the CA activity and diabetes
status may also be partially explained by the differing
MG levels among the individuals in PD group of our
study; however,MG levels were not determined in the
current study.
5. Conclusions
The potential differences in environmental and life-
style factors, as well as the fundamental differences in
BMI and age between the Indian and Finnish study
groups may explain the poor universal applicability
of δDOB18O as a biomarker in prediabetes screening.
In our study, fasting state δ18O was found to pos-
itively correlate with age, an anthropometric para-
meter showing, unintentionally, significant difference
between the two study groups and being higher in
PD group in comparison to NDC group. As for CA
activity, some earlier studies have suggested that it
reflects study subjects’ BMI; in our study population
of mainly middle-aged subjects, CA activity showed
negative correlation with BMI. Thus, it seems that
the application of δDOB18O as a CA activity and pre-
diabetes biomarker in individual patients requires
careful consideration of the multidimensional inter-
actions between several geographic, climatic, and
demographic variables. However, it is also possible
that the participants in the current study fulfilling
the diagnostic criteria of PD had already taken some
action to improve their PD state, and therefore the
differences between study groups may have beenmit-
igated. Furthermore, although δDOB18OandCAactiv-
ity did not seem to have a role as independent risk
predictors in clinical screening, we cannot exclude
the possibility that δ13C measurement could have an
added value as part of the noninvasive screening panel
including other validated measurements
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